Geneva Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
3,310
+16
+0.5% +$6.99K 0.03% 115
2026
Q1
$1.52M Sell
3,294
-627
-16% -$317K 0.03% 114
2025
Q4
$2.22M Sell
3,921
-43
-1% -$22.9K 0.04% 113
2025
Q3
$1.77M Sell
3,964
-149
-4% -$71.5K 0.03% 116
2025
Q2
$2.24M Sell
4,113
-138
-3% -$72.2K 0.04% 109
2025
Q1
$2.11M Buy
4,251
+553
+15% +$306K 0.04% 111
2024
Q4
$1.93M Sell
3,698
-265
-7% -$138K 0.03% 120
2024
Q3
$1.95M Sell
3,963
-345
-8% -$161K 0.03% 121
2024
Q2
$1.92M Sell
4,308
-1,082
-20% -$431K 0.03% 123
2024
Q1
$2.15M Buy
5,390
+911
+20% +$344K 0.04% 119
2023
Q4
$1.51M Buy
4,479
+1,936
+76% +$577K 0.03% 125
2023
Q3
$743K Sell
2,543
-75
-3% -$23.4K 0.02% 125
2023
Q2
$895K Buy
+2,618
New +$792K 0.02% 121

Other funds holding ISRG

Geneva Capital Management's ISRG Position: Q2 2026 in Review

Geneva Capital Management increased its Intuitive Surgical (ISRG) stake by 0.49% in Q2 2026, buying an estimated $6.99K and bringing the position to 3,310 shares worth $1.32M. The position accounts for 0.03% of the portfolio, ranked #115.

Geneva Capital Management first reported a position in ISRG in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.24M in Q2 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Geneva Capital Management held 3,310 shares of Intuitive Surgical worth $1.32M as of Q2 2026.
  • Geneva Capital Management bought 16 Intuitive Surgical shares in Q2 2026, an estimated $6.99K.
  • Intuitive Surgical made up 0.03% of Geneva Capital Management's portfolio in Q2 2026, its #115 holding.
  • Geneva Capital Management first reported a position in Intuitive Surgical in Q2 2023 and has held it in 13 quarters since.
  • Geneva Capital Management's Intuitive Surgical position peaked at $2.24M in Q2 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.